Skip to content

Clinical trials

Cognitive Dysfunction trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Not applicable Clear all

2,042 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20034
20043
20056
20069
200713
200812
200915
201023
201126
201239
201331
201443
201568
201677
2017122
2018119
2019130
2020116
2021170
2022174
2023199
2024228
2025221
2026181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed976
Recruiting357
Unknown status312
Not yet recruiting144
Active, not recruiting99
Terminated69
Withdrawn40
Enrolling by invitation38
Suspended7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of California, San Francisco25
VA Office of Research and Development23
Johns Hopkins University22
Riphah International University21
The Hong Kong Polytechnic University19
Icahn School of Medicine at Mount Sinai17
The University of Hong Kong17
Indiana University16
Massachusetts General Hospital16
Taipei Medical University16

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction2,042
Alzheimer Disease316
Dementia304
Memory Disorders80
Stroke75
Parkinson Disease67
Multiple Sclerosis47
Anxiety Disorders45
Neurocognitive Disorders44
Schizophrenia37

Trials

Showing 1 to 25 of 2,042. Each trial links to its page on Pharma Observatory.

1,942 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.